Two Day Veterinary Drug Approval Process and FDA Regulatory Oversight Seminar - Kansas City, MO, United States - May 17th-18th, 2018

DUBLIN, Jan. 17, 2018 /PRNewswire/ --

The "The Veterinary Drug Approval Process and FDA Regulatory Oversight: 2-day In-Person Seminar" conference has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The U.S. Food and Drug Administration's Center for Veterinary Medicine or CVM is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies.

For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.

This seminar on veterinary medicine regulations will provide attendees with an understanding of FDA's veterinary drug approval process.

This two day interactive course will cover:

    --  Premarket approval process
    --  Various sections of a New Animal Drug Application
    --  Strategies for navigating the FDA approval process and for expending
        product approval
    --  The nature of shared jurisdiction over veterinary products in certain
        cases

Learning Objectives:

    --  Understand how the U.S. Food and Drug Administration regulates
        veterinary drug product.
    --  Understand how FDA's Center for Veterinary Medicine is organized.
    --  Discuss the process by which veterinary drug products are reviewed and
        approved.
    --  Learn how to open an INAD File and request fee waivers.
    --  Obtain a working knowledge of various sections included within an NADA.
    --  Develop a deep understanding of what is needed to substantiate product
        characterization, target safety and effectiveness.
    --  Analyze FDA's rules governing chemistry, manufacturing and controls or
        CMC.
    --  Understand the various components of an animal field study to support
        product approval.
    --  Discuss the difference between FDA's various user fees and fee waivers.
    --  Identify the elements of an FDA compliant label.
    --  Develop a corporate compliance strategy covering labeling, marketing and
        advertising.
    --  Problem solving methods to mitigate regulatory enforcement risks.
    --  Explain how jurisdiction is split between various Federal agencies in a
        certain cases.
    --  Learn how animal feed, veterinary devices, OTC drug products and
        nutritional supplement are regulated in the U.S.

Who Should Attend:

    --  Personnel new to the Animal Health Industry
    --  CRO professionals
    --  Entrepreneurs looking to add value to their products
    --  Regulatory professionals
    --  Compliance professionals
    --  U.S. Agents of Foreign Corporations
    --  Process owners
    --  Document control specialists
    --  Record retention specialists
    --  Legal Professionals
    --  Financial Advisors and Institutional Investors
    --  Consultants, Inspectors and cGxP Experts

For more information about this conference visit https://www.researchandmarkets.com/research/mqs3tv/two_day?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/two-day-veterinary-drug-approval-process-and-fda-regulatory-oversight-seminar---kansas-city-mo-united-states---may-17th-18th-2018-300583971.html

SOURCE Research and Markets